Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › ketotifen

ketotifen

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ketotifen

4 trials tracked of ketotifen: 4 in phase 3 or 4.

4Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 4
  1. Phase 3 Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study Completed
  2. Phase 3 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis. Completed
  3. Phase 3 Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis. Completed
  4. Phase 3 A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Ketotifen shows significant improvements in hepatic steatosis and fibrosis indices compared with vitamin E in a pilot study of NAFLD
Gastroenterology RCT
Ketotifen shows significant improvements in hepatic steatosis and fibrosis indices compared with vitamin E in a pilot study of NAFLD Ketotifen beats Vitamin E for fatty liver disease in new trial
This randomized pilot study enrolled 60 individuals with non-alcoholic fatty liver disease (NAFLD) and followed them for 6.0 months.
New research shows a common allergy medicine reduces liver fat and scarring more effectively than Vitamin E for people with fatty liver dise…
Apr 27, 2026